(10 Mar 2022) The Microbiology Society and Institute of Microbiology, Chinese Academy of Sciences (IMCAS) have announced their transformative agreement starting in 2022. The Publish and Read model will allow researchers at affiliated institutions to publish an unlimited number of Open Access (OA) articles in hybrid and fully OA titles, as well as have full reading access to the Society’s journal portfolio.
The Institute of Microbiology, Chinese Academy of Sciences claims to be the largest microbiological research institution in China and historically one of the most prolific institutes worldwide. This deal demonstrates the reach of the Society’s model for sustainable Open Access and its relevance internationally to academic and government institutions, facilitating Open Access for more researchers across the globe.
The number of international institutions opting into Publish and Read agreements with the Society has doubled year-on-year since its launch in 2020.
Affiliated authors with Publish and Read institutions are entitled to unlimited OA publishing where any article published in Society journals where the corresponding author is from a Publish and Read institution will be OA by default; unlimited usage where any user associated with a Publish and Read institution can access the entire archive of Society content, back to 1947, for reading and for text and data mining.
Publish and Read will be across all the Society’s six journals, including hybrid titles Microbiology, Journal of General Virology, Journal of Medical Microbiology, International Journal of Systematic and Evolutionary Microbiology, and fully OA titles Access Microbiology, Microbial Genomics.